Skip to main content
. 2022 Jan 13;176:106083. doi: 10.1016/j.phrs.2022.106083

Fig. 8.

Fig. 8

XFBD treated LPS-induced acute lung injury through PD-1/IL17A pathway (A, C) The changes of macrophages in IL17A blocking antibody experiment. (B, D) The changes of neutrophils in IL17A blocking antibody. (E-H) The gene expression of Il17a, Pdcd1, Ccl2 and Cxcl10 in lung tissues of ALI mice after XFBD-H or IL17A mAb treatment, n = 3. Data were presented as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, vs. Model group.